Summit Global Investments’s Curis CRIS Stock Holding History

Summit Global Investments’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-48	Closed	-$216K	–	575
2021 Q1	$216K	Buy	+48	New	+$201K	0.01%	510

Other funds holding CRIS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Summit Global Investments's CRIS Position: Q2 2021 in Review

Summit Global Investments sold out of Curis (CRIS) in Q2 2021, closing a stake of 48 shares — an estimated $216K sold.

Summit Global Investments first reported a position in CRIS in Q1 2021 and held it in 1 quarter. The position peaked at $216K in Q1 2021. 127 funds tracked by Wall St. Rank hold CRIS as of Q2 2021.

Summit Global Investments reported no remaining Curis position as of Q2 2021 after selling out during the quarter.
Summit Global Investments sold 48 Curis shares in Q2 2021, an estimated $216K.
Summit Global Investments first reported a position in Curis in Q1 2021 and held it in 1 quarter.
Summit Global Investments's Curis position peaked at $216K in Q1 2021.
127 funds tracked by Wall St. Rank held Curis as of Q2 2021.

Based on Summit Global Investments's 13F filing for Q2 2021, filed 28 Jan 2022.